Skip to main content

Market Overview

Teladoc Shares Could Rise 40% Over The Next Year

Teladoc Shares Could Rise 40% Over The Next Year

Recent channel checks indicate robust growth for Teladoc Inc (NYSE: TDOC) over the next couple of years, backed by strong demand for telehealth, Chardan Capital Markets’ Steven Wardel said in a report.

He initiated coverage of the company with a Buy rating and a price target of $24.

Upside Potential

“Teladoc is mispriced and undervalued compared to its peers due to market concerns about its business model and its currently-negative earnings,” Wardel pointed out. He added, however, that Teladoc was a leader in telehealth services, that its business model was strong and that the company could achieve rapid margin expansion over the next year.

Wardel added that the current share price represented “a good entry point for the name,” and that shares had more than 40 percent upside potential.

Large Addressable Market And Strong Growth Prospects

The U.S. telehealth segment is estimated to be a $29 billion addressable market where penetration was less than 1 percent and growth was more than 30 percent. Teladoc has about a 70 percent market share, and checks indicate the brand has a strong presence, the analyst stated.

“Our channel check calls with employer and Managed Care Organization (MCO) leaders consistently rank telehealth as a top priority for 2017 among ancillary health benefits for the third year in a row, with strong interest in driving employee utilization of telehealth in order to drive down overall medical trend costs,” Wardel wrote. He added, “TDOC is a way for investors to participate in the themes of healthcare consumerization and cost savings.”

Latest Ratings for TDOC

Apr 2021Credit SuisseMaintainsOutperform
Apr 2021Canaccord GenuityMaintainsBuy
Apr 2021BTIGMaintainsBuy

View More Analyst Ratings for TDOC
View the Latest Analyst Ratings


Related Articles (TDOC)

View Comments and Join the Discussion!

Posted-In: Chardan Capital Markets Steven WardelAnalyst Color Long Ideas Price Target Initiation Analyst Ratings Trading Ideas Best of Benzinga

Latest Ratings

FIBKStephens & Co.Downgrades
LEAFCanaccord GenuityDowngrades8.5
AGMSidoti & Co.Downgrades115.0
KEXGabelli & Co.Downgrades
OCGNCantor FitzgeraldDowngrades11.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at